Long-Chain Polyunsaturated Fatty Acids and Their Metabolites Regulate Inflammation in Age-Related Macular Degeneration
Jiangbo Ren,Anli Ren,Xizhi Deng,Zhengrong Huang,Ziyu Jiang,Zhi Li,Yan Gong
DOI: https://doi.org/10.2147/JIR.S347231
IF: 4.5
2022-02-09
Journal of Inflammation Research
Abstract:Jiangbo Ren, 1, 2, &ast Anli Ren, 1, 2, &ast Xizhi Deng, 2 Zhengrong Huang, 1 Ziyu Jiang, 1 Zhi Li, 2 Yan Gong 1, 3 1 Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 2 Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 3 Human Genetics Resource Preservation Center of Wuhan University, Wuhan University, Wuhan, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan Gong; Zhi Li, Tel +86 27 6781 1461 ; +86 27 6781 2622 , Fax +86 27 6781 1471 ; +86 27 6781 3133 , Email ; Age-related macular degeneration (AMD) is a blinding eye disease, whose incidence strongly increases with ages. The etiology of AMD is complex, including aging, abnormal lipid metabolism, chronic inflammation and oxidative stress. Long-chain polyunsaturated fatty acids (LCPUFA) are essential for ocular structures and functions. This review summarizes the regulatory effects of LCPUFA on inflammation in AMD. LCPUFA are related to aging, autophagy and chronic inflammation. They are metabolized to pro- and anti-inflammatory metabolites by various enzymes. These metabolites stimulate inflammation in response to oxidative stress, causing innate and acquired immune responses. This review also discusses the possible clinical applications, which provided novel targets for the prevention and treatment of AMD and other age-related diseases. Keywords: inflammation, long-chain polyunsaturated fatty acids, age-related macular degeneration Age-related macular degeneration (AMD) is a disease that damages the macular region of the retina and leads to progressive loss of central vision, which is the leading cause of blindness in the elderly population. 1 The overall prevalence in Europe was 16.2% for AMD, and the number of global population with AMD will increase to 288 million by 2040. 2,3 AMD is not simply a "macular" disease, but involves the entire retina. 4 With aging, retinal pigment epithelium (RPE) cells lose the phagocytic and digestive ability at the outer membrane of the optic disc. The residual bodies of the disc membrane remain and deposit on Bruch's membrane, forming drusen and leading to macular degeneration. 5 Upon Bruch's membrane rupture, choroidal capillaries migrate through the ruptured Bruch's membrane into the RPE and subcutaneous space of retinal nerve, forming choroidal neovascularization (CNV, Figure 1). 6 Dry AMD, also named non-neovascular, non-exudative or atrophic AMD, is characterized by the development of drusen, 7 while wet AMD, also known as neovascular or exudative AMD, is characterized by CNV. 8 Figure 1 Composition of the retina and ocular neovascularization. Retinal vessels grow through the retinal nerve epithelium to form retinal neovascularization. The choriocapillaris enter under the RPE through the ruptured Bruch's membrane to form CNV. It is well recognized that AMD is a multifactorial disease, 9,10 including genetic predisposition, 11 oxidative stress, 12,13 neovascularization, 14,15 inflammatory responses 16 and remodeling processes of the retinal extracellular matrix. 17 Rozing et al proposed that the essence of AMD was a series of damages involved in aging and the consequently activated host immune responses to damages. 18 Low-grade inflammation is associated with many age-related complications including AMD and neurodegeneration. 19 Controlling low-grade inflammation can prevent or reduce age-related functional decline. 20 Pujol-Lereis et al stated that AMD resulted from three interrelated pathological processes, including inflammation, autophagy dysfunction and chronic oxidative stress, which led to RPE degeneration, ultimately photoreceptor cell death and vision loss. 21 Under oxidative stress, the drusen are formed in the retina, activating the complement system to trigger chronic inflammation, and subsequently activate immune cells, such as macrophages. 22 Invasive immune cells facilitate pathology in the retina, resulting in impairment of photoreceptor cells and Bruch's membrane integrity. 23 Although the progressive course of AMD is increasingly known, current medical treatments are still limited. 24–28 Intravitreal injection of anti-vascular endothelial growth factor (VEGF) is currently the most widely used therapy, 29,30 which still have many disadvantages, such as the loss of visual acuity in long-term treatment,<s -Abstract Truncated-
immunology